NO20072832L - Smertestillende middel - Google Patents

Smertestillende middel

Info

Publication number
NO20072832L
NO20072832L NO20072832A NO20072832A NO20072832L NO 20072832 L NO20072832 L NO 20072832L NO 20072832 A NO20072832 A NO 20072832A NO 20072832 A NO20072832 A NO 20072832A NO 20072832 L NO20072832 L NO 20072832L
Authority
NO
Norway
Prior art keywords
analgesic
painkiller
pain
nitrogen
heterocyclic group
Prior art date
Application number
NO20072832A
Other languages
English (en)
Norwegian (no)
Inventor
Kuniaki Kawamura
Naoki Izumimoto
Toshikazu Komagata
Tadatoshi Hashimoto
Hiroshi Nagabukuro
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of NO20072832L publication Critical patent/NO20072832L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20072832A 2004-11-04 2007-06-04 Smertestillende middel NO20072832L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004320583 2004-11-04
PCT/JP2005/020297 WO2006049248A1 (ja) 2004-11-04 2005-11-04 鎮痛剤

Publications (1)

Publication Number Publication Date
NO20072832L true NO20072832L (no) 2007-08-01

Family

ID=36319248

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072832A NO20072832L (no) 2004-11-04 2007-06-04 Smertestillende middel

Country Status (12)

Country Link
US (1) US8470845B2 (2)
EP (1) EP1820505A4 (2)
JP (1) JP4706636B2 (2)
KR (1) KR101285645B1 (2)
CN (1) CN101090722B (2)
AR (1) AR053098A1 (2)
CA (1) CA2586181C (2)
MX (1) MX2007005336A (2)
NO (1) NO20072832L (2)
PE (1) PE20060723A1 (2)
TW (1) TW200621785A (2)
WO (1) WO2006049248A1 (2)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007055184A1 (ja) * 2005-11-09 2007-05-18 Toray Industries, Inc. 機能性腸障害の治療または予防剤
WO2007072749A1 (ja) * 2005-12-21 2007-06-28 Toray Industries, Inc. 鎮咳剤
FR2902341B1 (fr) 2006-06-16 2011-02-25 Scras Utilisation therapeutique simultanee, separee ou etalee dans le temps d'au moins une neurotoxine botulique, et d'au moins un derive opiace
FR2910327B1 (fr) 2006-12-22 2013-04-26 Scras Utilisation d'au moins une neurotoxine botulique pour traiter la douleur induite par les traitements therapeutiques du virus du sida.
AU2008254038B2 (en) * 2007-05-21 2013-01-10 Toray Industries, Inc. Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation
ES2627217T3 (es) * 2007-05-21 2017-07-27 Toray Industries, Inc. Partículas micropulverizadas cristalinas
AU2008254039B2 (en) * 2007-05-21 2013-10-24 Toray Industries, Inc. Method for producing pharmaceutical tablet
FR2930447B1 (fr) 2008-04-25 2010-07-30 Sod Conseils Rech Applic Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur dans le cas de la neuropathie diabetique
DK3761982T3 (da) 2018-03-08 2025-01-02 Victoria Link Ltd Anvendelse af nalfurafin til behandling af demyeliniserende sygdomme

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4118823B1 (2) * 1964-02-03 1966-10-31
US3318884A (en) * 1965-07-21 1967-05-09 American Cyanamid Co Substituted 6-amino-6-demethoxythebaine and 6-amino-6-demethoxyoripavine derivatives
NL8102558A (nl) * 1981-05-25 1982-12-16 Alcoa Nederland Bv Lichtmast met versterking van de opening in het onderste gedeelte.
ES2121988T3 (es) * 1992-01-23 1998-12-16 Toray Industries Derivado de morfinano y uso medicinal.
NZ268969A (en) * 1993-07-23 1997-06-24 Toray Industries Morphinan derivatives and pharmaceutical compositions
AU5090796A (en) * 1995-03-03 1996-09-23 Algos Pharmaceutical Corporation Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence
AU6020300A (en) * 1999-07-19 2001-02-05 Toray Industries, Inc. Remedies or preventives for frequent urination or urinary incontinence
DE19939044A1 (de) * 1999-08-18 2001-03-15 Gruenenthal Gmbh Verwendung von Morphinanderivaten als Arzneimittel
JP4340437B2 (ja) 2000-10-31 2009-10-07 レンセラール ポリテクニック インスティチュート ８−カルボキサミド−２，６−メタノ−３−ベンズアゾシン
BR0314754A (pt) * 2002-10-09 2005-07-26 Toray Industries Agente terapêutico ou profilático para a frequência urinária ou a incontinência urinária ou um seu sal de adição de ácido farmaceuticamente aceitável, método para terapia ou profilaxia para frequência urinária, urgência urinária ou incontinência urinária, uso de um derivado de morfina tendo um grupo heterocìclico contendo nitrogênio ou de um seu sal de adição de ácido farmaceuticamente aceitável, derivado de morfina ou um seu sal de adição de ácido farmaceuticamente aceitável, produto farmacêutico, e, composição farmacêutica
JP4118824B2 (ja) 2004-02-24 2008-07-16 株式会社日立製作所 優先パケットの遅延を最小化するシェーピング装置
JP4118826B2 (ja) 2004-03-01 2008-07-16 リオン株式会社 補聴器用ケースなどの製造方法及びその装置
TW200533355A (en) 2004-03-30 2005-10-16 Toray Industries Antipruritic agent

Also Published As

Publication number Publication date
HK1115808A1 (en) 2008-12-12
CA2586181C (en) 2012-11-27
US20070299100A1 (en) 2007-12-27
KR20070085436A (ko) 2007-08-27
CA2586181A1 (en) 2006-05-11
TW200621785A (en) 2006-07-01
WO2006049248A1 (ja) 2006-05-11
TWI356826B (2) 2012-01-21
US8470845B2 (en) 2013-06-25
PE20060723A1 (es) 2006-08-29
CN101090722B (zh) 2011-12-21
MX2007005336A (es) 2007-06-25
CN101090722A (zh) 2007-12-19
AR053098A1 (es) 2007-04-25
EP1820505A1 (en) 2007-08-22
JP4706636B2 (ja) 2011-06-22
KR101285645B1 (ko) 2013-07-12
EP1820505A4 (en) 2010-01-20
JPWO2006049248A1 (ja) 2008-08-07

Similar Documents

Publication Publication Date Title
NO20072832L (no) Smertestillende middel
ATE479687T1 (de) Kinaseinhibitoren
WO2009001060A3 (en) Use of compounds for preparing anti-tuberculosis agents
WO2006066133A3 (en) Histone deacetylase inhibitors
WO2005112646A3 (en) Treatment of diet-related conditions using phospholipase-a2 inhibitors comprising indoles and related compounds
MY146989A (en) Kinase inhibitors
WO2005074603A3 (en) Aminobenzoxazoles as therapeutic agents
WO2005110410A3 (en) Kinase inhibitors as therapeutic agents
WO2008055236A3 (en) Mapk/erk kinase inhibitors
WO2007028135A3 (en) Imidazopyridine compounds
WO2007023110A3 (en) P38 map kinase inhibitors and methods for using the same
WO2005075425A3 (en) Substituted bisarylurea derivatives as kinase inhibitors
NO20062399L (no) Transdermale smertestillende systemer som har redusert misbrukspotensial
EA200500203A1 (ru) Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат
TW200615266A (en) Organic compounds
WO2007084390A3 (en) Histone deacetylase inhibitors
AU2009215534A8 (en) Compounds that are ERK inhibitors
WO2007112014A3 (en) New therapeutic combinations for the treatment of depression
NO20092692L (no) MAPK/ERK kinaseinhibitorer
TN2009000151A1 (en) Mapk/erk kinase inhibitors
GEP20166481B (en) (crystalline forms of hydrochloride salt of (4a-r, 9a-s)-1-(1h-benzoimidazole-5-carbonyl)-2, 3, 4, 4a, 9, 9a-hexa- hydro-1h-indeno [2, 1-b] pyridine-6-carbonitrile and their use as hsd 1 inhibitors
WO2007059230A3 (en) Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors
WO2007099171A3 (en) Bicyclo-pyrazoles active as kinase inhibitors
WO2009051223A1 (ja) 白内障処置のための医薬組成物
ATE483716T1 (de) Lösungsmittelfreies amorphes rapamycin

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application